Ocular Therapeutix OCUL Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's accounts receivable?
- Ocular Therapeutix (OCUL) reported accounts receivable of $24.35M in Q1 2026.
- How has Ocular Therapeutix's accounts receivable changed year-over-year?
- Ocular Therapeutix's accounts receivable decreased by 3.5% year-over-year, from $25.22M to $24.35M.
- What is the long-term trend for Ocular Therapeutix's accounts receivable?
- Over 5 years (2020 to 2025), Ocular Therapeutix's accounts receivable has grown at a 20.1% compound annual growth rate (CAGR), from $12.25M to $30.65M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.